http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2608894-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad51edabc7e68b89a389ec876664d209
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
filingDate 2012-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10b0afce5ff4d25f059d319600156584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce57fa35da82e1105d6c1e773dc5978
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be980a9d05c596832c505b9ab55f3294
publicationDate 2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2608894-C2
titleOfInvention CRYSTALLINE FORMS OF 5α-ANDROSTANE-3β,5,6β-TRIOL AND METHODS FOR PRODUCTION THEREOF
abstract FIELD: chemistry. n SUBSTANCE: present invention relates to four crystalline forms of (crystalline forms A, B, C and D) 5α-androstane-3β,5,6β-triol (YC-6) and to methods of their production. n EFFECT: said crystalline forms have better stability compared to existing forms, contain a smaller amount of impurities and are safer. n 10 cl, 12 dwg, 15 ex
priorityDate 2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012003802-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2196143-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21941165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426248706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887

Total number of triples: 39.